Barinthus Biotherapeutics BRNS
BRNS
$0.74 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Barinthus Biotherapeutics (BRNS) Interest & Investment Income (2021 - 2026)

Updated

Barinthus Biotherapeutics' Interest & Investment Income came in at $343,000 for Q2 2026, down 34.4% from $523,000 a year earlier and down 2.0% from the prior quarter.

Analysis

Barinthus Biotherapeutics (BRNS) Interest & Investment Income (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Barinthus Biotherapeutics reported Interest & Investment Income of $1.57 million, down 33.1% year-over-year; for FY2025, it was $1.96 million, down 26.9% from FY2024.

  • Interest & Investment Income has declined in each of the last three years, though with a four-year compound annual growth rate of 459.3% (FY2021 to FY2025).
  • Going back by year, Interest & Investment Income was $2.68 million in FY2024 (-6.9%), $2.88 million in FY2023 (-7.3%), $3.1 million in FY2022 and $2,000 in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Interest & Investment Income since Q3 2023.
  • Year-over-year, Interest & Investment Income has declined for six consecutive quarters, with growth averaging 6.8% over the last eight quarters.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q3 2024 (growth of 221.9%), and the weakest in Q3 2023 (a decline of 80.9%).
  • Business Quant data shows BRNS's Interest & Investment Income at $350,000 (Q1 2026), $406,000 (Q4 2025) and $472,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Barinthus Biotherapeutics 30.23 Mn 30.29 Mn - 343,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 343,000.00
Mar 31, 2026 350,000.00
Dec 31, 2025 406,000.00
Sep 30, 2025 472,000.00
Jun 30, 2025 523,000.00
Mar 31, 2025 556,000.00
Dec 31, 2024 637,000.00
Sep 30, 2024 631,000.00
Jun 30, 2024 635,000.00
Mar 31, 2024 775,000.00
Dec 31, 2023 571,000.00
Sep 30, 2023 196,000.00
Jun 30, 2023 522,000.00
Mar 31, 2023 1.59 Mn
Dec 31, 2022 1.33 Mn
Sep 30, 2022 1.02 Mn
Jun 30, 2022 669,000.00
Mar 31, 2022 83,000.00
Mar 31, 2021 2,000.00
API Access

Barinthus Biotherapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BRNS&period=max&api_key=YOUR_API_KEY